Notice of Contract Action - 36C25026Q0321.pdf

NOTICE OF PROPOSED CONTRACT ACTION

Pharmaceutical Reverse Distribution Services

Department of Veterans Affairs

VA Northeast Ohio Healthcare System (VANEOHS)

This is a notice of a proposed contract action for commercial services. It is issued to satisfy publicizing requirements and is not a request for quotations or proposals. No solicitation document is being issued at this time.

The Department of Veterans Affairs, VA Northeast Ohio Healthcare System (VANEOHS), intends to acquire pharmaceutical reverse distribution services for seven VA pharmacy locations in Northeast Ohio, including the Wade Park inpatient/outpatient pharmacy, the Kent Infusion

Center, and multiple Community Based Outpatient Clinic (CBOC) pharmacies.

The Contractor shall provide comprehensive pharmaceutical reverse distribution services to support these facilities. At a minimum, required services include onsite identification and preparation of expired and short-dated pharmaceuticals; return processing of both controlled and non-controlled items; coordination of manufacturer credits through the VA’s current

Pharmaceutical Prime Vendor (PPV); provision of detailed credit and disposal reporting; and compliant destruction of non-returnable and hazardous pharmaceuticals. All work shall be performed in full compliance with applicable DEA, EPA, OSHA, DOT, FDA, and VA requirements and policies.

The Government anticipates awarding a firm-fixed-price contract using a flat fee per site visit.

The fee shall not be commission-based and shall be independent of the credit value realized from returns. The anticipated period of performance is one (1) base year with four (4) one-year option periods. The estimated value of this acquisition is greater than $25,000 but does not exceed the simplified acquisition threshold, and the Government intends to use simplified acquisition procedures in accordance with FAR Part 13 and applicable synopsis requirements in FAR

Subpart 5.2. This requirement is not set aside for small business; all responsible sources may respond.

A draft Performance Work Statement (PWS) for this requirement is attached to this notice.

Interested vendors are strongly encouraged to review the PWS in full prior to submitting a written response. The Government considers the attached PWS to contain a complete description of the current requirement but reserves the right to revise the PWS prior to any request for quotation (RFQ).

Any vendor questions regarding this notice or the draft PWS shall be submitted in writing no later than 2:00 PM Eastern Time on February 20, 2026. The Government may, at its discretion, post consolidated questions and answers as an amendment to this notice. Questions that are clearly addressed by the PWS as written may not receive an individual response.

Vendors that wish to be considered for potential receipt of an RFQ shall submit a brief written response no later than 2:00 PM Eastern Time on February 28, 2026. At a minimum, responses shall:

• Confirm the vendor’s current capability to perform all tasks in the attached PWS, including onsite service, controlled substance handling, and hazardous waste disposal.

• Confirm the vendor’s status as a DEA registrant authorized to handle Schedule II–V controlled substances for reverse distribution purposes.

• Confirm the vendor’s ability to function as a reverse distributor compatible with the VA’s current Pharmaceutical Prime Vendor (PPV).

• Confirm that the vendor has an active registration in SAM.gov at the time of response.

Generic marketing materials or responses that do not specifically address these minimum elements and demonstrate a clear, present capability to perform this requirement may not be reviewed or considered further.

This notice is for planning and publicizing purposes only, does not commit the Government to award a contract, and does not obligate the Government to pay any costs incurred in preparing a response. The Government anticipates requesting written quotations directly from those responsible sources it determines capable and interested based on their written responses to this notice, using simplified acquisition procedures.